Delisting riskPopularity #4,431
VistaGen Therapeutics (VTGN)
Develops intranasal pherine candidates for psychiatric, women's-health, and cancer-supportive-care conditions.
$0.3778
vs last close+0.13 (+50.28%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 26.54% | 11.78M shares | |
|---|---|---|---|
| 58 holders · as of Jun 30, 2026 | |||
| Insiders | 0.35% | 155.5K shares | |
| 5 holders · as of Jul 2, 2026 | |||
| Other | 73.11% | 32.44M shares | |
| remainder | |||
44.38M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
58 holders · 11.78M shares · 9 new positions · 28 increased · 14 reduced · 13 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Commodore Capital LP | 2.79M | 6.28% | +2.79Mnew | Aug 14, 2026 |
| Vanguard Capital Management LLC | 1.57M | 3.55% | 0 | Aug 13, 2026 |
| Two Sigma Investments, LP | 848.0K | 1.91% | +378.4K | Aug 14, 2026 |
| Acadian Asset Management LLC | 794.6K | 1.79% | +204.9K | Aug 13, 2026 |
| Renaissance Technologies LLC | 730.5K | 1.65% | +439.2K | Aug 13, 2026 |
| Stempoint Capital LP | 616.7K | 1.39% | 0 | Aug 14, 2026 |
| Ikarian Capital, LLC | 519.1K | 1.17% | 0 | Aug 14, 2026 |
| Advisorshares Investments LLC | 438.6K | 0.99% | +161.5K | Aug 11, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Commodore Capital LP | 9.90% | 4.38M | 13G | Feb 17, 2026 |
| Biotechnology Value Fund L P | 5.40% | 1.59M | 13G | Feb 14, 2025 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.